{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:18Z","timestamp":1786979958831,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Kurscheid\/H\u00fchnlein Stiftung","award":["11-2025"],"award-info":[{"award-number":["11-2025"]}]},{"name":"F\u00f6rderkreis des TumorCentrums e.V"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00292-026-01547-w","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:40:24Z","timestamp":1774266024000},"page":"190-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SARIFA: Literatur\u00fcbersicht und Expertenmeinung zum neuen morphologischen Biomarker","SARIFA: Literature review and expert opinion on the new morphological biomarker"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-1432","authenticated-orcid":false,"given":"Patrick","family":"Adam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"M\u00e4rkl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"1547_CR1","volume":"487","author":"S Bertz-Kalinka","year":"2025","unstructured":"Bertz-Kalinka\u00a0S, Reitsam\u00a0N, Grosser\u00a0B et\u00a0al (2025) Stroma AReactive Invasion Front Areas (SARIFA) - a promising prognostic biomarker in muscle-invasive urothelial bladder cancer. Virchows Archiv 487:550","journal-title":"Virchows Archiv"},{"key":"1547_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11771-9","volume":"24","author":"JS Enke","year":"2024","unstructured":"Enke\u00a0JS, Gross\u00a0M, Grosser\u00a0B et\u00a0al (2024) SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer. BMC Cancer 24:65","journal-title":"BMC Cancer"},{"key":"1547_CR3","doi-asserted-by":"crossref","unstructured":"Feng WW, Zuppe HT, Kurokawa M (2023) The Role of CD36 in Cancer Progression and Its Value as a\u00a0Therapeutic Target. Cells 12","DOI":"10.3390\/cells12121605"},{"key":"1547_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/his.15501","volume":"87","author":"S Foersch","year":"2025","unstructured":"Foersch\u00a0S, Harb\u00a0N, Litmeyer\u00a0AS et\u00a0al (2025) Stroma areactive invasion front areas (SARIFA) in 1,298 pT3\/pT4 colorectal cancers: A strong prognostic parameter complementing established morphological criteria. Histopathology 87:464\u2013473","journal-title":"Histopathology"},{"key":"1547_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12519-9","volume":"24","author":"P Grochowski","year":"2024","unstructured":"Grochowski\u00a0P, Grosser\u00a0B, Sommer\u00a0F et\u00a0al (2024) The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma. BMC Cancer 24:768","journal-title":"BMC Cancer"},{"key":"1547_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41416-023-02515-4","volume":"130","author":"B Grosser","year":"2024","unstructured":"Grosser\u00a0B, Emmerson\u00a0J, Reitsam\u00a0NG et\u00a0al (2024) Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. Br J Cancer 130:457\u2013466","journal-title":"Br J Cancer"},{"key":"1547_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/path.5810","volume":"256","author":"B Grosser","year":"2022","unstructured":"Grosser\u00a0B, Gl\u00fcckstein\u00a0MI, Dhillon\u00a0C et\u00a0al (2022) Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes. J\u00a0Pathol 256:71\u201382","journal-title":"J Pathol"},{"key":"1547_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s10120-023-01436-8","volume":"27","author":"B Grosser","year":"2023","unstructured":"Grosser\u00a0B, Heyer\u00a0CM, Austgen\u00a0J et\u00a0al (2023) Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a\u00a0tumor-adipocyte interaction indicating an altered immune response. Gastric Cancer 27:72\u201385","journal-title":"Gastric Cancer"},{"key":"1547_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00292-024-01368-9","volume":"45","author":"B Grosser","year":"2024","unstructured":"Grosser\u00a0B, Reitsam\u00a0NG, Grochowski\u00a0P et\u00a0al (2024) SARIFA \u2013 ein neuer entit\u00e4ten\u00fcbergreifender Biomarker. Pathologie 45:397\u2013403","journal-title":"Pathologie"},{"key":"1547_CR10","volume":"26","author":"B Grosser","year":"2024","unstructured":"Grosser\u00a0B, Schiele\u00a0S, Reitsam\u00a0NG et\u00a0al (2024) SARIFA, a new prognostic histomorphological biomarker in gastric cancer identifies cases with a distinct biology \u2013 a post hoc analysis of the ST03 trial. Oncology Research and Treatment 26:26","journal-title":"Oncology Research and Treatment"},{"key":"1547_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan\u00a0D (2022) Hallmarks of Cancer: New Dimensions. Cancer Discov 12:31\u201346","journal-title":"Cancer Discov"},{"key":"1547_CR12","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1158\/2767-9764.CRC-23-0073","volume":"3","author":"Q Hu","year":"2023","unstructured":"Hu\u00a0Q, Wang\u00a0Y, Yao\u00a0S et\u00a0al (2023) Desmoplastic Reaction Associates with Prognosis and Adjuvant Chemotherapy Response in Colorectal Cancer: A Multicenter Retrospective Study. Cancer Res Commun 3:1057\u20131066","journal-title":"Cancer Res Commun"},{"key":"1547_CR13","doi-asserted-by":"crossref","unstructured":"Jakab A, Zarandy L, Kocsmar I et\u00a0al. (2024) Local Invasion Patterns Characterized by SARIFA and Tumor Budding Differ and Have Distinct Prognostic Significance in Esophageal Adenocarcinoma and Squamous Cell Carcinoma. Cancers (Basel) 16","DOI":"10.3390\/cancers16183144"},{"key":"1547_CR14","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS (2021) oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform 22","DOI":"10.1093\/bib\/bbab260"},{"key":"1547_CR15","doi-asserted-by":"crossref","unstructured":"Martin B, Grosser B, Kempkens L et\u00a0al. (2021) Stroma AReactive Invasion Front Areas (SARIFA)-A New Easily to Determine Biomarker in Colon Cancer-Results of a\u00a0Retrospective Study. Cancers (Basel) 13","DOI":"10.3390\/cancers13194880"},{"key":"1547_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10555-022-10059-x","volume":"41","author":"A Mukherjee","year":"2022","unstructured":"Mukherjee\u00a0A, Bilecz\u00a0AJ, Lengyel\u00a0E (2022) The adipocyte microenvironment and cancer. Cancer Metastasis Rev 41:575\u2013587","journal-title":"Cancer Metastasis Rev"},{"key":"1547_CR17","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-19-1999","volume":"80","author":"A Mukherjee","year":"2020","unstructured":"Mukherjee\u00a0A, Chiang\u00a0CY, Daifotis\u00a0HA et\u00a0al (2020) Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance. Cancer Res 80:1748\u20131761","journal-title":"Cancer Res"},{"key":"1547_CR18","doi-asserted-by":"crossref","unstructured":"Mustapic K, Dolonga P, Ivanovic T et\u00a0al. (2025) SARIFA Is Associated with Lymph Node Metastases in PT3 and PT4 Gastric Cancers. Cancers (Basel) 17","DOI":"10.3390\/cancers17213593"},{"key":"1547_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-024-00349-z","volume":"12","author":"K Offermans","year":"2024","unstructured":"Offermans\u00a0K, Reitsam\u00a0NG, Simons\u00a0C et\u00a0al (2024) The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer patients. Cancer Metab 12:21","journal-title":"Cancer Metab"},{"key":"1547_CR20","doi-asserted-by":"crossref","unstructured":"Reitsam NG, Grosser B, Dintner S et\u00a0al. (2026) Tissue-Based Multiomic Exploratory Analysis of the uPa\/uPAR System and Matrix Metalloproteinases in SARIFA-Positive Gastrointestinal Cancers. Pathobiology:1-17","DOI":"10.1159\/000549919"},{"key":"1547_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00589-6","volume":"4","author":"NG Reitsam","year":"2024","unstructured":"Reitsam\u00a0NG, Grosser\u00a0B, Steiner\u00a0DF et\u00a0al (2024) Converging deep learning and human-observed tumor-adipocyte interaction as a biomarker in colorectal cancer. Commun Med (Lond) 4:163","journal-title":"Commun Med (Lond)"},{"key":"1547_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41417-023-00695-y","volume":"31","author":"NG Reitsam","year":"2024","unstructured":"Reitsam\u00a0NG, Grozdanov\u00a0V, Loffler\u00a0CML et\u00a0al (2024) Novel biomarker SARIFA in colorectal cancer: highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology. Cancer Gene Ther 31:207\u2013216","journal-title":"Cancer Gene Ther"},{"key":"1547_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41416-025-03034-0","volume":"132","author":"NG Reitsam","year":"2025","unstructured":"Reitsam\u00a0NG, M\u00e4rkl\u00a0B (2025) Stroma AReactive Invasion Front Areas (SARIFA) and the tumour immune microenvironment in colorectal cancer. Br J Cancer 132:983\u2013985","journal-title":"Br J Cancer"},{"key":"1547_CR24","doi-asserted-by":"crossref","unstructured":"Reitsam NG, M\u00e4rkl B, Dintner S et\u00a0al. (2023) Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA). Cancers (Basel) 15","DOI":"10.3390\/cancers15030994"},{"key":"1547_CR25","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/PAS.0000000000002408","volume":"49","author":"NG Reitsam","year":"2025","unstructured":"Reitsam\u00a0NG, Offermans\u00a0K, Simons\u00a0C et\u00a0al (2025) Prognostic and Predictive Value of SARIFA-status Within Molecular Subgroups of Colorectal Cancer: Insights From the Netherlands Cohort Study. Am J Surg Pathol 49:956\u2013969","journal-title":"Am J Surg Pathol"},{"key":"1547_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig\u00a0F, Schulze\u00a0A (2016) The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer 16:732\u2013749","journal-title":"Nat Rev Cancer"},{"key":"1547_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai\u00a0E, Astsaturov\u00a0I, Cukierman\u00a0E et\u00a0al (2020) A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer 20:174\u2013186","journal-title":"Nat Rev Cancer"},{"key":"1547_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2319254121","volume":"121","author":"S Sheppard","year":"2024","unstructured":"Sheppard\u00a0S, Srpan\u00a0K, Lin\u00a0W et\u00a0al (2024) Fatty acid oxidation fuels natural killer cell responses against infection and cancer. Proc Natl Acad Sci U S A 121:e2319254121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1547_CR29","doi-asserted-by":"crossref","unstructured":"Tapiainen VV, Sirni\u00f6 P, Elomaa H et\u00a0al. (2025) Stroma AReactive Invasion Front Areas (SARIFA), tumour immune microenvironment, and survival in colorectal cancer. British Journal of Cancer","DOI":"10.1038\/s41416-025-02972-z"},{"key":"1547_CR30","doi-asserted-by":"crossref","unstructured":"Ulase D, Behrens HM, R\u00f6cken C (2024) Stroma AReactive Invasion Front Areas (SARIFA) predict poor survival in adenocarcinomas of the stomach and gastrooesophageal junction: a\u00a0validation study. Virchows Arch","DOI":"10.1007\/s00428-024-03826-4"},{"key":"1547_CR31","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.7150\/thno.36037","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang\u00a0J, Li\u00a0Y (2019) CD36 tango in cancer: signaling pathways and functions. Theranostics 9:4893\u20134908","journal-title":"Theranostics"},{"key":"1547_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-021-00427-2","volume":"4","author":"E Wulczyn","year":"2021","unstructured":"Wulczyn\u00a0E, Steiner\u00a0DF, Moran\u00a0M et\u00a0al (2021) Interpretable survival prediction for colorectal cancer using deep learning. NPJ Digit Med 4:71","journal-title":"NPJ Digit Med"},{"key":"1547_CR33","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang\u00a0D, Liu\u00a0J, Qian\u00a0H et\u00a0al (2023) Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp Mol Med 55:1322\u20131332","journal-title":"Exp Mol Med"},{"key":"1547_CR34","doi-asserted-by":"publisher","first-page":"904","DOI":"10.2337\/dci22-0047","volume":"46","author":"OHY Yu","year":"2023","unstructured":"Yu\u00a0OHY, Suissa\u00a0S (2023) Metformin and Cancer: Solutions to a Real-World Evidence Failure. Diabetes Care 46:904\u2013912","journal-title":"Diabetes Care"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-026-01547-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-026-01547-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-026-01547-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:58:49Z","timestamp":1777013929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-026-01547-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1547"],"URL":"https:\/\/doi.org\/10.1007\/s00292-026-01547-w","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"value":"2731-7188","type":"print"},{"value":"2731-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Adam und B.\u00a0M\u00e4rkl geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}